Financial News · Live Terminal

Page 1770 of 2033

US Patent Board Ruling Invalidates Trina Solar Patent Claims Against Canadian Solar

Canadian Solar (CSIQ) said Monday the Patent Trial and Appeal Board of the US Patent and Trademark Office invalidated claims of two Tunnel Oxide Passivated Contact solar cell patents previously asserted by Trina Solar against some of its subsidiaries.The company said that this decision reinforces its track record in managing international intellectual property disputes, while noting that it remains focused on organic research and development, with an effective system to defend its global IP rights.President Colin Parkin said the company opposes what it described as the "abusive use of IP" to hinder competition, and will continue to defend its business interests.

$CSIQ

Mining & Metals55d ago

OpenText Appoints James McGourlay as President, Chief Client Officer

OpenText (OTEX.TO) on Monday said that James McGourlay will transition from interim chief executive officer to president, chief client officer, effective April 20, 2026."In this role, McGourlay will lead OpenText's global client experience, professional services, and renewals organization," said the company.The company also said that McGourlay will report to Ayman Antoun, Chief Executive Officer of OpenText as of April 20, 2026, and will continue to serve as a member of the OpenText Executive Leadership Team. The company further said that McGourlay has held senior leadership roles across sales, customer operations, and executive management at OpenText."James is a proven leader with more than 30 years at OpenText, and his career has consistently been anchored in our clients and what is essential to their success," said Tom Jenkins, Executive Chairman of the Board and Chief Strategy Officer, OpenText. "As Chief Client Officer, James will strengthen client experience and renewals, support cloud adoption, and advance OpenText's position as the trusted partner for data and security for enterprise AI."The company also announced that effective April 20, 2026, Paul Duggan will be stepping down from his position as president, chief customer officer and will continue to serve as executive vice president, special advisor. The company added that Duggan will also remain a member of the OpenText Executive Leadership Team until his departure from OpenText on July 1, 2026.

$OTEX.TO

Asia55d ago

Bank of Maharashtra Declares Final Dividend

Bank of Maharashtra (NSE:MAHABANK, BOM:532525) declared a final dividend of 1.20 rupees per equity share of 10 rupees each for the financial year ended March 31.

$BOM:532525$NSE:MAHABANK

Asia55d ago

Elife Holdings Extends Long Stop for Share Placing

Elife Holdings (HKG:0223) further extended the long stop date of a share placing agreement to May 12 from April 21, according to a Monday Hong Kong bourse filing.The extension came as the placing agent needed more time to finalize the placing with potential investors.The firm had, in January, agreed to place up to 271.2 million new shares at HK$0.102 to raise roughly HK$27.1 million in net proceeds.

$HKG:0223

Mining & Metals55d ago

TransAlta Names Mike Politeski CFO

TransAlta (TA.TO) said Monday that it appointed Mike Politeski as executive vice president for finance and chief financial officer, effective May 1.The company also named Grant Arnold as EVP for growth and chief commercial officer, effective May 6.TransAlta said the appointments correspond with the transition of current EVP and CFO, Joel Hunter, to the role of president and chief executive officer, effective April 30.Current President and CEO John Kousinioris is retiring April 30.Politeski has over 25 years of experience across capital markets, financial strategy, risk, treasury, financial reporting and tax. He most recently served as senior vice president for finance and treasurer at Veren.Meanwhile, Arnold has over 30 years of leadership, commercial and technical experience in the power generation and energy sector. He served as president and CEO of BluEarth Renewables.

$TA.TO

Asia55d ago

CGS International Downgrades Thai Airways International to Hold from Add; Price Target is THB6.40

$BKK:THAI

Research55d ago

Goldman Sachs Upgrades Waterbridge Infrastructure to Buy From Neutral, Adjusts Price Target to $32 From $26

Waterbridge Infrastructure LLC Class A (WBI) has an average rating of overweight and mean price target of $30.56, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$WBI

Research55d ago

Stifel Upgrades Plexus to Buy From Hold, Adjusts Price Target to $250 From $200

Plexus (PLXS) has an average rating of overweight and mean price target of $210.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$PLXS

Asia55d ago

Phillip Securities Upgrades PTT Exploration and Production to Buy from Accumulate; Price Target is THB40

$BKK:PTTEP

Treasury55d ago

Risk Appetite "On the Run" As Middle East Tensions Flare Again, Says Scotiabank

Risk appetite is "on the run" to start the fresh trading week, said Derek Holt, Vice-President & Head of Capital Markets Economics, at Scotiabank in his 'Daily Points' note Monday.Holt noted oil was up by 5%-6% a barrel, while United States equity futures were down by about 0.5%, with European equities down by about double that amount.He also noted the US dollar (USD) was slightly firmer against most majors except for the Canadian dollar (CAD or loonie) and Norway's krone (NOK), while sovereign bond yields were up by around 2bps to 6bps across regions and maturities, with Europe underperforming U.S. Treasuries.On geopolitics, Holt said U.S. President Donald Trump appears to have "grossly overstated" progress toward an agreement with Iran on Friday.Other than that there was, he added, very light calendar-based risk through the overnight. German producer prices soared in March (+2.5% m/m, consensus 1.4%). China left the 1- and 5-year Loan Prime Rates unchanged at 3% and 3.5% respectively which surprised no one.

$$CAD$$CXY$$NOK$$USD

Asia55d ago

UOB Kay Hian Upgrades KCE Electronics to Buy from Sell; Price Target is THB32

$BKK:KCE

Research55d ago

Goldman Sachs Upgrades TC Energy to Neutral From Sell, Adjusts Price Target to CA$84.74 From CA$72

TC Energy (TRP) has an average rating of overweight and mean price target of CA$90, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$TRP

Research55d ago

Avendus Spark Starts Tilaknagar Industries at Buy with INR550 Price Target

$BOM:507205$NSE:TI

Research55d ago

Elara Securities India Starts Sagility at Buy with INR54 Price Target

$BOM:544282$NSE:SAGILITY

Research55d ago

Phillip Securities Upgrades Kasikornbank to Accumulate from Neutral; Price Target is THB187

$BKK:KBANK

Research55d ago

Phillip Securities Upgrades Bangkok Bank to Buy From Accumulate; Price Target is THB182

$BKK:BBL

Asia55d ago

Raasi Refractories CFO Resigns

Refractory items manufacturer, Raasi Refractories (BOM:502271) said Chief Financial Officer Sistla Subrahmanya Sastry has resigned, effective April 20, citing personal reasons, according to a same-day filing on BSE.

$BOM:502271

Research55d ago

Phillip Securities Upgrades Krung Thai Bank to Accumulate from Neutral; Price Target is THB33

$BKK:KTB

Research55d ago

Jefferies Upgrades Oscar Health to Hold From Underperform, Adjusts Price Target to $16 From $10

Oscar Health (OSCR) has an average rating of hold and mean price target of $16.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$OSCR

Asia55d ago

Sino Biopharmaceutical Unit Gets China Nod to Market Cancer Drug

Sino Biopharmaceutical (HKG:1177) said Benmelstobart in combination with Anlotinib obtained marketing approval from China's National Medical Products Administration, according to a Monday Hong Kong bourse filing.The approval is for the treatment of advanced or unresectable alveolar soft part sarcoma.Benmelstobart and Anlotinib are category 1 innovative drugs developed by Chia Tai Tianqing Pharmaceutical Group, a unit of the company.

$HKG:1177

Showing 35381-35400 of 40655